Works matching IS 22351795 AND DT 2023 AND VI 12 AND IP 4

Results: 9
    1

    Erratum.

    Published in:
    2023
    Publication type:
    Correction Notice
    2

    Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 321, doi. 10.1159/000529574
    By:
    • Kudo, Masatoshi;
    • Aoki, Tomoko;
    • Ueshima, Kazuomi;
    • Tsuchiya, Kaoru;
    • Morita, Masahiro;
    • Chishina, Hirokazu;
    • Takita, Masahiro;
    • Hagiwara, Satoru;
    • Minami, Yasunori;
    • Ida, Hiroshi;
    • Nishida, Naoshi;
    • Ogawa, Chikara;
    • Tomonari, Tetsu;
    • Nakamura, Noriaki;
    • Kuroda, Hidekatsu;
    • Takebe, Atsushi;
    • Takeyama, Yoshifumi;
    • Hidaka, Masaaki;
    • Eguchi, Susumu;
    • Chan, Stephen L
    Publication type:
    Article
    3

    Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 339, doi. 10.1159/000529608
    By:
    • Monin, Malte Benedikt;
    • Baier, Leona I.;
    • Gorny, Jens G.;
    • Berger, Moritz;
    • Zhou, Taotao;
    • Mahn, Robert;
    • Sadeghlar, Farsaneh;
    • Möhring, Christian;
    • Boesecke, Christoph;
    • van Bremen, Kathrin;
    • Rockstroh, Jürgen K.;
    • Strassburg, Christian P.;
    • Eis-Hübinger, Anna-Maria;
    • Schmid, Matthias;
    • Gonzalez-Carmona, Maria A.
    Publication type:
    Article
    4

    Front & Back Matter.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 288, doi. 10.1159/000534256
    Publication type:
    Article
    5
    6
    7

    Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
    By:
    • Merle, Philippe;
    • Kudo, Masatoshi;
    • Edeline, Julien;
    • Bouattour, Mohamed;
    • Cheng, Ann-Lii;
    • Chan, Stephen Lam;
    • Yau, Thomas;
    • Garrido, Marcelo;
    • Knox, Jennifer;
    • Daniele, Bruno;
    • Breder, Valeriy;
    • Lim, Ho Yeong;
    • Ogasawara, Sadahisa;
    • Cattan, Stéphane;
    • Chao, Yee;
    • Siegel, Abby B.;
    • Martinez-Forero, Iván;
    • Wei, Ziwen;
    • Liu, Chih-Chin;
    • Finn, Richard S.
    Publication type:
    Article
    8

    Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 297, doi. 10.1159/000528537
    By:
    • Sekino, Yuta;
    • Tateishi, Ryosuke;
    • Fukumitsu, Nobuyoshi;
    • Okumura, Toshiyuki;
    • Maruo, Kazushi;
    • Iizumi, Takashi;
    • Numajiri, Haruko;
    • Mizumoto, Masashi;
    • Minami, Tatsuya;
    • Nakagomi, Ryo;
    • Sato, Masaya;
    • Asaoka, Yoshinari;
    • Nakagawa, Hayato;
    • Hayata, Yuki;
    • Fujiwara, Naoto;
    • Shiina, Shuichiro;
    • Koike, Kazuhiko;
    • Sakurai, Hideyuki
    Publication type:
    Article
    9